Global Liquid Biopsy Diagnostics Market: by Type (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Exosomes, Extracellular Vesicles, Cell-Free DNA (cfDNA), Others), Application (Cancer Diagnosis, Treatment Monitoring, Risk Assessment, Early Detection, Therapy Selection, Others), Distribution Channels (Hospitals, Diagnostic Laboratories, Research Institutes, CROs, Academic Institutes, Others), Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Digital PCR, Microarray, In Situ Hybridization, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025

1. Global Liquid Biopsy Diagnostics Market Outlook

2. Global Liquid Biopsy Diagnostics Market Executive Summary

2.1. Global Market Revenue Size (USD Million) (2020-2035)

2.2. Key Trends By Segments (2020-2035)

2.3. Key Trends By Global (2020-2035)

3. Global Liquid Biopsy Diagnostics Market Key Vendors Analysis

3.1. Liquid Biopsy Diagnostics Market Regulatory Framework

3.2. Liquid Biopsy Diagnostics Market New Business and Ease of Doing Business Index

3.3. Liquid Biopsy Diagnostics Market Recent Developments

3.4. Top Liquid Biopsy Diagnostics Market Buyers Details By Global

3.5. Top Liquid Biopsy Diagnostics Market Suppliers Details By Global

3.6. Case Studies of Successful Key Ventures

3.7. Top Players Comparative Analysis

3.7.1. Country/Regions

3.8. Key Vendors

3.8.1. Top 5 Liquid Biopsy Diagnostics Market Vendors Pricing Analysis

3.8.2. Liquid Biopsy Diagnostics Market Product Benchmarking

3.8.3. Liquid Biopsy Diagnostics Market Future Investment Plans

3.9. Liquid Biopsy Diagnostics Market – Forces

3.9.1. Liquid Biopsy Diagnostics Market Drivers

3.9.2. Liquid Biopsy Diagnostics Market Restraints

3.9.3. Liquid Biopsy Diagnostics Market Challenges

3.9.3.1. Porter's Five Forces Analysis

3.9.3.1.1. Liquid Biopsy Diagnostics Market Bargaining Power of Suppliers

3.9.3.1.2. Liquid Biopsy Diagnostics Market Bargaining Power of Buyers

3.9.3.1.3. Liquid Biopsy Diagnostics Market Threat of New Entrants

3.9.3.1.4. Liquid Biopsy Diagnostics Market Threat of Substitutes

3.9.3.1.5. Liquid Biopsy Diagnostics Market Degree of Competition

4. Global Liquid Biopsy Diagnostics Market Revenue (USD Million) Size (2020-2035)- By Country Analysis

4.1. North America Liquid Biopsy Diagnostics Market Revenue (USD Million) By Country (2020-2035)

4.1.1. US

4.1.2. Canada

4.1.3. Mexico

4.2. Europe Liquid Biopsy Diagnostics Market Revenue (USD Million) By Country (2020-2035)

4.2.1. Germany

4.2.2. France

4.2.3. UK

4.2.4. Italy

4.2.5. Spain

4.2.6. Netherlands

4.2.7. Poland

4.2.8. Belgium

4.2.9. Denmark

4.2.10. Sweden

4.2.11. Ukraine

4.2.12. Russia

4.2.13. Rest of Europe

4.3. APAC Liquid Biopsy Diagnostics Market Revenue (USD Million) By Country (2020-2035)

4.3.1. China

4.3.2. India

4.3.3. Japan

4.3.4. Taiwan

4.3.5. Vietnam

4.3.6. Philippines

4.3.7. Singapore

4.3.8. Australia

4.3.9. South Korea

4.3.10. Rest of APAC

4.4. South America Liquid Biopsy Diagnostics Market Revenue (USD Million) By Country (2020-2035)

4.4.1. Brazil

4.4.2. Argentina

4.4.3. Peru

4.4.4. Colombia

4.4.5. Chile

4.4.6. Rest of South America

4.5. Middle East Liquid Biopsy Diagnostics Market Revenue (USD Million) By Country (2020-2035)

4.5.1. Kuwait

4.5.2. Saudi Arabia

4.5.3. Oman

4.5.4. Qatar

4.5.5. UAE

4.5.6. Egypt

4.5.7. Rest of Middle East

4.6. Africa Liquid Biopsy Diagnostics Market Revenue (USD Million) By Country (2020-2035)

4.6.1. South Africa

4.6.2. Chad

4.6.3. Mali

4.6.4. Sudan

4.6.5. Algeria

4.6.6. Rest of Africa

5. Global Liquid Biopsy Diagnostics Market Revenue (USD Million) Size (2020-2035)- By Type

5.1. Circulating Tumor Cells (CTCs)

5.2. Circulating Tumor DNA (ctDNA)

5.3. Exosomes

5.4. Extracellular Vesicles

5.5. Cell-Free DNA (cfDNA)

5.6. Others

6. Global Liquid Biopsy Diagnostics Market Revenue (USD Million) Size (2020-2035)- By Application

6.1. Cancer Diagnosis

6.2. Treatment Monitoring

6.3. Risk Assessment

6.4. Early Detection

6.5. Therapy Selection

6.6. Others

7. Global Liquid Biopsy Diagnostics Market Revenue (USD Million) Size (2020-2035)- By Technology

7.1. Next-Generation Sequencing (NGS)

7.2. Polymerase Chain Reaction (PCR)

7.3. Digital PCR

7.4. Microarray

7.5. In Situ Hybridization

7.6. Others

8. Global Liquid Biopsy Diagnostics Market Revenue (USD Million) Size (2020-2035)- By Distribution Channels

8.1. Hospitals

8.2. Diagnostic Laboratories

8.3. Research Institutes

8.4. CROs

8.5. Academic Institutes

8.6. Others

9. Global Liquid Biopsy Diagnostics Market Revenue (USD Million) Size (2020-2035)- By Organization Size

9.1. Small

9.2. Medium

9.3. Large

10. Company Profile Analysis

10.1. Guardant Health

10.1.1. Vendors Overview

10.1.2. Business Portfolio

10.1.3. Geographical Portfolio

10.1.4. Customers

10.1.5. Financial Analysis

10.2. Foundation Medicine

10.3. Biocept

10.4. QIAGEN

10.5. Roche Diagnostics

10.6. Illumina

10.7. Thermo Fisher Scientific

10.8. Myriad Genetics

10.9. Bio-Rad Laboratories

10.10. Genomic Health

10.11. Freenome

10.12. Liquid Biotech USA

10.13. Natera

10.14. Menarini Silicon Biosystems

10.15. Epigenomics AG

11. Sources Covered

11.1. Primary Sources

11.2. Secondary Sources